ALPHA TEKNOVA, INC. (TKNO) Gross Margin
- Gross margin · 12 months: Value 34.60%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 34.60% | Gross profit / revenue. Period ending 2026-06-30. $15.12M ÷ $43.70M × 100 ≈ 34.60% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 15.12M USD | Gross Profit |
| Revenue | 43.70M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 28.58M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $15.12M | $43.70M | $28.58M | 34.60% |
| 2026-03-31 | $14.22M | $41.80M | $27.58M | 34.01% |
| 2025-12-31 | $13.44M | $40.52M | $27.08M | 33.17% |
| 2025-09-30 | $12.32M | $39.80M | $27.48M | 30.97% |
| 2025-06-30 | $9.21M | $38.92M | $29.71M | 23.66% |
| 2025-03-31 | $8.03M | $38.25M | $30.22M | 20.99% |
| 2024-12-31 | $7.23M | $37.74M | $30.51M | 19.16% |
| 2024-09-30 | $6.44M | $36.35M | $29.91M | 17.71% |
| 2024-06-30 | $7.82M | $34.94M | $27.12M | 22.38% |
| 2024-03-31 | $10.08M | $36.85M | $26.77M | 27.36% |
| 2023-12-31 | $10.30M | $36.68M | $26.39M | 28.07% |
| 2023-09-30 | $11.07M | $36.71M | $25.64M | 30.16% |
| 2023-06-30 | $14.37M | $39.23M | $24.86M | 36.63% |
| 2023-03-31 | $14.55M | $39.39M | $24.84M | 36.93% |
| 2022-12-31 | $17.48M | $41.42M | $23.94M | 42.19% |
| 2022-09-30 | $20.34M | $43.64M | $23.29M | 46.62% |
| 2022-06-30 | $19.84M | $42.34M | $22.50M | 46.86% |
| 2022-03-31 | $17.95M | $38.96M | $21.02M | 46.06% |
| 2021-12-31 | $17.62M | $36.89M | $19.27M | 47.76% |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) |
| 2020-12-31 | $17.75M | $31.30M | $13.54M | 56.73% |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |